Jonathan Kipnis | |
---|---|
Nationality | Israeli, American |
Alma mater | |
Known for | discovery of brain lymphatic vessels |
Scientific career | |
Fields | Neuroimmunology |
Institutions | |
Doctoral advisor | Michal Schwartz |
Website | Lab website |
Jonathan Kipnis is a neuroscientist, immunologist, and professor of pathology and immunology at the Washington University School of Medicine. [1] His lab studies interactions between the immune system and nervous system. [2] He is best known for his lab's discovery of meningeal lymphatic vessels in humans and mice, which has impacted research on neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis, [3] neuropsychiatric disorders, such as anxiety, and neurodevelopmental disorders such as autism and Rett syndrome.
Kipnis was born into a Jewish family in Tbilisi, Georgia. His father and maternal grandmother were both physicians and his mother was an academic with a focus in Russian literature and language. Surrounded by physicians, Kipnis knew from a young age that he wanted to cure diseases. [4] He received his undergraduate degree in biology at Tel Aviv University in Ramat Aviv, Israel [5] in 1998, and his Master's in neurobiology at the Weizmann Institute of Science in Rehovot, Israel in 1999. [5]
For his graduate training, Kipnis remained at the Weizmann Institute of Science. He first worked with Moshe Oren in cancer immunology, [6] but was inspired by Michal Schwartz, to pursue a PhD in neuroimmunology. [5] He joined Schwartz's lab the year that they discovered the therapeutic benefit of T cells in spinal cord and brain injury, a pioneering finding that began the study of the protective roles of autoimmunity in CNS disease. [7] This was the beginning of Kipnis' career exploring the connections between the brain and the immune system. [8]
In the Schwartz Lab, Kipnis' work focused on T cell based autoimmune reactions in CNS injury and neurodegeneration. [9] Kipnis elucidated the pleiotropic roles of regulatory T cells in CNS injury versus CNS homeostasis. [10] By depleting naturally occurring regulatory T cells after CNS injury, he was able to improve neuronal survival in mice. [10] However, by up-regulating effector autoimmune T cells through immunization with CNS antigen, he was able to improve recovery after CNS injury. These results showed that the immune system's intrinsic mechanisms to protect against autoimmunity, might not be beneficial when insults demand autoimmune effector function for tissue maintenance. [10]
Kipnis remained at the Weizmann for his postdoctoral training in Schwartz's lab. In this period he and other members of the lab, discovered that brain antigen specific T cells play a role in neurogenesis and cognitive functions, such as memory and spatial learning. [11] This was one of the seminal findings showing that the immune system, through T cells, plays a role in cognition and brain homeostasis. [12]
Kipnis joined the University of Virginia School of Medicine (UVA) in 2007, where he later became a Harrison Distinguished Professor and chair of the department of neuroscience. He also directed the Center for Brain Immunology and Glia (BIG Center) at UVA. [13] In 2019, he accepted an offer to join the Washington University School of Medicine faculty via the BJC Investigators Program. He is primarily appointed in the department of pathology and immunology, and secondarily in neurology, neuroscience, and neurosurgery. [1] Kipnis is also a Gutenberg Forschungskolleg Fellow and supervises a working group at the University of Mainz. [14]
Kipnis is credited with the 2014 discovery of meningeal lymphatic vessels, a recently discovered network of conventional lymphatic vessels located parallel to the dural sinuses and meningeal arteries of the mammalian central nervous system (CNS). As a part of the lymphatic system, the meningeal lymphatics are responsible for draining immune cells, small molecules, and excess fluid from the CNS and into the deep cervical lymph nodes. While it was initially believed that both the brain and meninges were devoid of lymphatic vasculature, the 2015 Nature paper by Jonathan Kipnis and his postdoctoral fellow Antoine Louveau reporting their discovery was cited more than 3000 times by 2022 [15]
His discovery of meningeal lymphatic vessels was included in Scientific American's "Top 10 Science Stories of 2015", Science Magazine's "Breakthrough of the Year", Huffington Post's "Eight Fascinating Things We Learned About the Mind in 2015" and the National Institutes of Health's director Francis Collins year end review. [2] [16]
Other research has included the 2015 discovery that the immune system directly affects social behavior and that IFN-gamma is necessary for social development. [17] [18] This expands upon his work as a graduate student, when he discovered that mice lacking T-cells had cognitive impairments. [13] [19]
His lab also elucidated the role of meningeal gamma delta (γδ) T cells in anxiety behavior,. [20] [21] finding that γδ T cells are resident in high numbers in the meningeal immune compartment, and that they actively transcribe the cytokine IL-17a at homeostasis. [22] They further discovered that the release of IL-17a from γδ T cells was correlated with anxiety behavior in mice, finding high expression of IL-17a receptor in the prefrontal cortex glutamatergic neurons, and discovered that when they knocked down IL-17a receptor in cortical glutamatergic neurons, this recapitulated the anxiety phenotype in mice. [23]
He and his group in 2015 investigated CD4+ T-cells protection and repair of neurons after injury to the spinal cord and brain. [24] A collaboration with Kodi Ravichandran characterized the generation of neurons in adult brains and the removal of dead neurons by phagocytic cells. [25]
In 2016, and his group identified type 2 innate lymphocytes in the meninges near the lymphatic vessels his lab previously discovered. These cells have previously have been found in the gut, which suggests a link between the brain and the microbiome. [26] In mice, these cells were activated by IL-33 after spinal cord injury. [27]
Kipnis' work has been funded by the Simons Foundation Autism Research Initiative, [28] National Institutes of Health, the Hartwell Foundation, and the Cure Alzheimer's Fund. [13] In 2018, he was awarded the NIH's prestigious Director's Pioneer Award and $5.6 million in additional research funding. [29]
Kipnis has drawn fire for discouraging a former graduate student from reporting allegations of sexual misconduct towards her supervising post-doctoral candidate, confirmed by screenshotted text messages, and did not report the incident to Title IX investigators, stating "You don’t need [an] investigation now, even though you will most probably win." [33] While initially covered by the Washington University student newspaper, [34] this incident was later corroborated in an independent investigation by Stat News. [33] Emails with lab members shared with Stat News also revealed concerns about the Kipnis lab’s drinking culture, which were the subject of a university investigation. Per the Stat News report, there has been controversy about the university potentially mishandling the case, evidenced by a letter from the medical school dean describing Kipnis as supportive and prompt in his response and that failure to reach out to Title IX office was the result of incorrect advice from a program administrator as well as lax enforcement of Washington University School of Medicine's mandatory reporting system.
Year | Title [35] | Publication | Author(s) | Volume/Issue Citation |
---|---|---|---|---|
2021 | Functional characterization of the dural sinuses as a neuroimmune interface | Cell | Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T, Wall M, Papadopoulos Z, Kanamori M, Salvador AF, Baker W, Lemieux M, Da Mesquita S, Cugurra A, Fitzpatrick J, Sviben S, Kossina R, Bayguinov P, Townsend RR, Zhang Q, Erdmann-Gilmore P, Smirnov I, Lopes MB, Herz J, Kipnis J. | 10.1016/j.cell.2020.12.040 |
2021 | Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma | Science | Cugurra A, Mamuladze T, Rustenhoven J, Dykstra T, Beroshvili G, Greenberg ZJ, Baker W, Papadopoulos Z, Drieu A, Blackburn S, Kanamori M, Brioschi S, Herz J, Schuettpelz LG, Colonna M, Smirnov I, Kipnis J. | 10.1126/science.abf7844 |
2019 | Bypassing the blood-brain barrier | Science | Rustenhoven J, Kipnis J. | 10.1126/science.aay0479 |
2018 | Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease | Nature | Sandro Da Mesquita, Antoine Louveau, Andrea Vaccari, Igor Smirnov, R. Chase Cornelison, Kathryn M. Kingsmore, Christian Contarino, Suna Onengut-Gumuscu, Emily Farber, Daniel Raper, Kenneth E. Viar, Romie D. Powell, Wendy Baker, Nisha Dabhi, Robin Bai, Rui Cao, Song Hu, Stephen S. Rich, Jennifer M. Munson, M. Beatriz Lopes, Christopher C. Overall, Scott T. Acton & Jonathan Kipnis. | doi:10.1038/s41586-018-0368-8 |
2016 | Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour | Nature | Filiano AJ, Xu Y, Tustison NJ, Marsh RL, Baker W, Smirnov I, Overall CC, Gadani SP, Turner SD, Weng Z, Peerzade SN, Chen H, Lee KS, Scott MM, Beenhakker MP, Litvak V, Kipnis J. | doi:10.1038/nature18626 |
2015 | Structural and functional features of central nervous system lymphatic vessels | Nature | Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J. | doi:10.1038/nature14432 |
The lymphatic system, or lymphoid system, is an organ system in vertebrates that is part of the immune system, and complementary to the circulatory system. It consists of a large network of lymphatic vessels, lymph nodes, lymphoid organs, lymphoid tissues and lymph. Lymph is a clear fluid carried by the lymphatic vessels back to the heart for re-circulation. The Latin word for lymph, lympha, refers to the deity of fresh water, "Lympha".
Susumu Tonegawa is a Japanese scientist who was the sole recipient of the Nobel Prize for Physiology or Medicine in 1987 for his discovery of V(D)J recombination, the genetic mechanism which produces antibody diversity. Although he won the Nobel Prize for his work in immunology, Tonegawa is a molecular biologist by training and he again changed fields following his Nobel Prize win; he now studies neuroscience, examining the molecular, cellular and neuronal basis of memory formation and retrieval.
Neuroimmunology is a field combining neuroscience, the study of the nervous system, and immunology, the study of the immune system. Neuroimmunologists seek to better understand the interactions of these two complex systems during development, homeostasis, and response to injuries. A long-term goal of this rapidly developing research area is to further develop our understanding of the pathology of certain neurological diseases, some of which have no clear etiology. In doing so, neuroimmunology contributes to development of new pharmacological treatments for several neurological conditions. Many types of interactions involve both the nervous and immune systems including the physiological functioning of the two systems in health and disease, malfunction of either and or both systems that leads to disorders, and the physical, chemical, and environmental stressors that affect the two systems on a daily basis.
The neuroimmune system is a system of structures and processes involving the biochemical and electrophysiological interactions between the nervous system and immune system which protect neurons from pathogens. It serves to protect neurons against disease by maintaining selectively permeable barriers, mediating neuroinflammation and wound healing in damaged neurons, and mobilizing host defenses against pathogens.
The glia limitans, or the glial limiting membrane, is a thin barrier of astrocyte foot processes associated with the parenchymal basal lamina surrounding the brain and spinal cord. It is the outermost layer of neural tissue, and among its responsibilities is the prevention of the over-migration of neurons and neuroglia, the supporting cells of the nervous system, into the meninges. The glia limitans also plays an important role in regulating the movement of small molecules and cells into the brain tissue by working in concert with other components of the central nervous system (CNS) such as the blood–brain barrier (BBB).
Interleukin 19 (IL-19) is an immunosuppressive protein that belongs to the IL-10 cytokine subfamily.
The deep cervical lymph nodes are a group of cervical lymph nodes in the neck that form a chain along the internal jugular vein within the carotid sheath.
Certain sites of the mammalian body have immune privilege, meaning they are able to tolerate the introduction of antigens without eliciting an inflammatory immune response. Tissue grafts are normally recognised as foreign antigens by the body and attacked by the immune system. However, in immune privileged sites, tissue grafts can survive for extended periods of time without rejection occurring. Immunologically privileged sites include:
Gamma delta T cells are T cells that have a γδ T-cell receptor (TCR) on their surface. Most T cells are αβ T cells with TCR composed of two glycoprotein chains called α (alpha) and β (beta) TCR chains. In contrast, γδ T cells have a TCR that is made up of one γ (gamma) chain and one δ (delta) chain. This group of T cells is usually less common than αβ T cells. Their highest abundance is in the gut mucosa, within a population of lymphocytes known as intraepithelial lymphocytes (IELs).
Interleukin-17A is a protein that in humans is encoded by the IL17A gene. In rodents, IL-17A used to be referred to as CTLA8, after the similarity with a viral gene.
Protective autoimmunity is a condition in which cells of the adaptive immune system contribute to maintenance of the functional integrity of a tissue, or facilitate its repair following an insult. The term ‘protective autoimmunity’ was coined by Prof. Michal Schwartz of the Weizmann Institute of Science (Israel), whose pioneering studies were the first to demonstrate that autoimmune T lymphocytes can have a beneficial role in repair, following an injury to the central nervous system (CNS). Most of the studies on the phenomenon of protective autoimmunity were conducted in experimental settings of various CNS pathologies and thus reside within the scientific discipline of neuroimmunology.
The glymphatic system is a system for waste clearance in the central nervous system (CNS) of vertebrates. According to this model, cerebrospinal fluid (CSF) flows into the paravascular space around cerebral arteries, combining with interstitial fluid (ISF) and parenchymal solutes, and exiting down venous paravascular spaces. The pathway consists of a para-arterial influx route for CSF to enter the brain parenchyma, coupled to a clearance mechanism for the removal of interstitial fluid (ISF) and extracellular solutes from the interstitial compartments of the brain and spinal cord. Exchange of solutes between CSF and ISF is driven primarily by arterial pulsation and regulated during sleep by the expansion and contraction of brain extracellular space. Clearance of soluble proteins, waste products, and excess extracellular fluid is accomplished through convective bulk flow of ISF, facilitated by astrocytic aquaporin 4 (AQP4) water channels.
Neuroinflammation is inflammation of the nervous tissue. It may be initiated in response to a variety of cues, including infection, traumatic brain injury, toxic metabolites, or autoimmunity. In the central nervous system (CNS), including the brain and spinal cord, microglia are the resident innate immune cells that are activated in response to these cues. The CNS is typically an immunologically privileged site because peripheral immune cells are generally blocked by the blood–brain barrier (BBB), a specialized structure composed of astrocytes and endothelial cells. However, circulating peripheral immune cells may surpass a compromised BBB and encounter neurons and glial cells expressing major histocompatibility complex molecules, perpetuating the immune response. Although the response is initiated to protect the central nervous system from the infectious agent, the effect may be toxic and widespread inflammation as well as further migration of leukocytes through the blood–brain barrier may occur.
The meningeal lymphatic vessels are a network of conventional lymphatic vessels located parallel to the dural venous sinuses and middle meningeal arteries of the mammalian central nervous system (CNS). As a part of the lymphatic system, the meningeal lymphatics are responsible for draining immune cells, small molecules, and excess fluid from the CNS into the deep cervical lymph nodes. Cerebrospinal fluid, and interstitial fluid are exchanged, and drained by the meningeal lymphatic vessels.
Michal Schwartz is a professor of neuroimmunology at the Weizmann Institute of Science. She is active in the field of neurodegenerative diseases, particularly utilizing the immune system to help the brain fight terminal neurodegenerative brain diseases, such as Alzheimer's disease and dementia.
Robyn S. Klein is an American neuroimmunologist as well as the Vice Provost and Associate Dean for Graduate Education at Washington University in St. Louis. Klein is also a professor in the Departments of Medicine, Anatomy & Neurobiology, and Pathology & Immunology. Her research explores the pathogenesis of neuroinflammation in the central nervous system by probing how immune signalling molecules regulate blood brain barrier permeability. Klein is also a fervent advocate for gender equity in STEM, publishing mechanisms to improve gender equity in speakers at conferences, participating nationally on gender equity discussion panels, and through service as the president of the Academic Women’s Network at the Washington University School of Medicine.
Gloria Choi is an American neuroscientist and neuroimmunologist and the Samuel A. Goldblith Career Development Professor in the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology. Choi is known for elucidating the role of the immune system in the development of autism spectrum disorder-like phenotypes. Her lab currently explores how sensory experiences drive internal states and behavioural outcomes through probing the olfactory system as well as the neuroimmune system.
Katerina Akassoglou is a neuroimmunologist who is a Senior Investigator and Director of In Vivo Imaging Research at the Gladstone Institutes. Akassoglou holds faculty positions as a Professor of Neurology at the University of California, San Francisco. Akassoglou has pioneered investigations of blood-brain barrier integrity and development of neurological diseases. She found that compromised blood-brain barrier integrity leads to fibrinogen leakage into the brain inducing neurodegeneration. Akassoglou is internationally recognized for her scientific discoveries.
Asya Rolls is an Israeli psychoneuroimmunologist and International Howard Hughes Medical Institute Investigator and a Professor at the Immunology and Center of Neuroscience at Technion within the Israel Institute of Technology. Rolls leads a lab that explores how the nervous system affects immune responses and thus physical health. Her recent work has highlighted how the brain's reward system is implicated in the placebo response and how brain-immune interactions can be harnessed to find and destroy tumors.
The subarachnoid lymphatic-like membrane (SLYM) is a recently described anatomical structure in the human brain that was proposed in 2023 as a possible fourth layer of the meninges.
{{cite web}}
: Missing or empty |title=
(help)